Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Huggins C, Hodges CV (2002) Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. J Urol 167:948–951
2. Schulman CC, Irani J, Morote J et al (2010) Androgen-deprivation therapy in prostate cancer: a European expert panel review. Eur Urol (Suppl 9):675–691
3. Mottet N, Bellmunt J, Bolla M et al (2011) EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 59:572–583
4. Leitlinienprogramm Onkologie der AWMW, Deutschen Krebsgesellschaft e. V., Deutschen Krebshilfe e. V. (2011) Interdisziplinäre Leitlinie der Qualität S 3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms. Version 2.0–1. Aktualisierung 2011
5. Locke JA, Guns ES, Lubik AA et al (2008) Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer. Cancer Res 68:6407–6415
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献